2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2022-08-20±³À°ÀÏÀÚ : 2022-08-20
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
(¿Â-¿ÀÇÁº´Çà)2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320
À̸ÞÀÏ :
office@thyroid.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-20 Hall A 08:30~08:50 Clonal History and Genetic Predictors of Transformation in Cancer ¹Ú¼º¿(Áö³ðÀλçÀÌÆ®)
±³À°½Ã°£ 08-20 Hall A 08:50~09:10 NTRK and RET Fusion Directed Therapy in Thyroid Cancer ¹Ú¿µÁÖ(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 08-20 Hall A 09:10~09:30 Application of Cancer Organoids in Precision Medicine Àå¼¼Áø(¿ï»êÀÇ´ë º´¸®°ú)
Åä·Ð 08-20 Hall A 09:30~09:40 ÅäÀÇ ()
±³À°½Ã°£ 08-20 Hall A 09:40~10:00 RFA for Benign Thyroid Nodules: Considerations for Good Outcome ¼ºÁø¿ë(´ë¸²¼º¸ðº´¿ø ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08-20 Hall A 10:00~10:20 Image Guided Intervention of Parathyroid Disease ±èÁöÈÆ(¼¿ïÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08-20 Hall A 10:20~10:40 Image Guided Intervention of Recurrent Thyroid Cancer Á¤¼Ò·É(°¡Å縯ÀÇ´ë ¿µ»óÀÇÇаú)
Åä·Ð 08-20 Hall A 10:40~10:50 ÅäÀÇ ()
ÈÞ½Ä 08-20 Hall A 10:50~11:10 Coffee Break ()
±³À°½Ã°£ 08-20 Hall A 11:10~12:10 New Horizons: Emerging Therapies and Targets in Thyroid Cancer Matthew Ringel(The Ohio State University Wexner Medical Center)
±âŸ 08-20 Hall A 12:10~12:30 ÃÑȸ ()
½Ä»ç 08-20 Hall A 12:30~13:30 Á¡½É½Ä»ç ()
±³À°½Ã°£ 08-20 Hall A 13:30~14:20 Robotic Thyroid Surgery: Yonsei Experience Á¤¿õÀ±(¿¬¼¼ÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 08-20 Hall A 14:20~14:40 New Grading System of MTC ¿øÀç°æ(¼¿ïÀÇ´ë º´¸®°ú)
±³À°½Ã°£ 08-20 Hall A 14:40~15:00 Calcitonin Negative MTC ±è¼®¸ð(¿¬¼¼ÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 08-20 Hall A 15:00~15:20 Genomic and Tranomic Characterization of MTC °¿¹Àº(Ãæ³²ÀÇ´ë ³»°ú)
±³À°½Ã°£ 08-20 Hall A 15:20~15:40 New Imaging and Radioligand Therapy for MTC ÃÖÈ«À±(¼¿ïÀÇ´ë ÇÙÀÇÇаú)
±³À°½Ã°£ 08-20 Hall A 15:40~15:50 ÅäÀÇ ()
ÈÞ½Ä 08-20 Hall A 15:50~16:10 Coffee Break ()
±³À°½Ã°£ 08-20 Hall A 16:10~16:50 Science or science fiction? Critical reading of scientific papers ¹ÚµµÁØ(¼¿ïÀÇ´ë ³»°ú)
±âŸ 08-20 Hall A 16:50~17:50 Topic Highlight ()
±âŸ 08-20 Hall B 08:30~09:40 Free Paper 3 ()
±âŸ 08-20 Hall B 09:40~10:50 Free Paper 4 ()
±³À°½Ã°£ 08-20 Hall B 14:20~14:40 Updates of 2021 Korean TIRADS Lexicons Á¤»õ·Ò(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08-20 Hall B 14:40~15:00 Imaging Classification of Cervical Lymph Nodes ÀÌÁö¿¹(¼¿ïÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08-20 Hall B 15:00~15:20 Preparation for the RAI Therapy ÀÌÀαâ(¿øÀڷº´¿ø ÇÙÀÇÇаú)
±³À°½Ã°£ 08-20 Hall B 15:20~15:40 Updates of RAI Therapy : Indications and Doses ÀÌ»ó¿ì(°æºÏÀÇ´ë ÇÙÀÇÇаú)
Åä·Ð 08-20 Hall B 15:40~15:50 ÅäÀÇ ()
ÈÞ½Ä 08-20 Hall B 15:50~16:10 Coffee Break ()
±³À°½Ã°£ 08-20 Hall B 16:10~16:30 ÀӽŰú °©»ó¼±Áúȯ Áø·á±Ç°í¾È ¾ÈÈ¿µ(Áß¾ÓÀÇ´ë ³»°ú)
±³À°½Ã°£ 08-20 Hall B 16:30~16:50 °©»ó¼±°áÀý Áø·á±Ç°í¾È ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)
Åä·Ð 08-20 Hall B 16:50~17:00 ÆгÎÅäÀÇ ³ªµ¿±Ô Á¤Âù±Ç ±èÈñ°æ ±è¼±¿í ÀÓâÈÆ(°¸ª¾Æ»êº´¿ø ¿µ»óÀÇÇаú °¡Å縯ÀÇ´ë º´¸®°ú Àü³²ÀÇ´ë ³»°ú ¼º±Õ°üÀÇ´ë ³»°ú Â÷ÀÇ°ú´ë ³»°ú)